Andrew Bryant
Jan Lecouturier
Giovany Orozco Leal
Dr Vicky Brocklebank
Dr Sonya Carnell
et al. | Eculizumab withdrawal and monitoring in atypical haemolytic uraemic syndrome (SETS aHUS): a multicentre, open label, prospective, single arm trial | 2025 |
|
Andrew Bryant
| Neoadjuvant chemotherapy before surgery versus surgery followed by chemotherapy for initial treatment in advanced epithelial ovarian cancer | 2025 |
|
Dr John Bourke
Andrew Bryant
Alexis Burn
Dr Thomas Chadwick
Professor Michela Guglieri
et al. | Preventing Cardiomyopathy in Duchenne Muscular Dystrophy: Long-Term Follow-Up of Patients in the Randomised, Placebo-Controlled Drug-Trial of Perindopril and Bisoprolol | 2025 |
|
Giovany Orozco Leal
Professor Luke Vale
Dr Vicky Brocklebank
Andrew Bryant
Dr Thomas Chadwick
et al. | The cost-effectiveness of replacing lifelong therapy of eculizumab with a strategy of disease monitoring for eligible atypical haemolytic uraemic syndrome (aHUS) patients: an economic evaluation of the SETS aHUS trial | 2025 |
|
Eugenie Johnson
Fiona Stewart
Sheila Wallace
Andrew Bryant
| Conservative, physical and surgical interventions for managing faecal incontinence and constipation in adults with central neurological diseases | 2024 |
|
Professor Andrew Fisher
Professor Helen Hancock
Professor James Wason
Dr Michael Grayling
Dr Joanne Lally
et al. | Extracorporeal Photopheresis (ECP) in the Treatment of Chronic Lung Allograft Dysfunction (CLAD): a prospective, multicentre, open-label, randomised controlled trial studying the addition of ECP to standard care in the treatment of bilateral lung transplant patients with CLAD (E-CLAD UK) | 2024 |
|
Dr Theophile Bigirumurame
Shaun Hiu
Professor Dawn Teare
Professor James Wason
Andrew Bryant
et al. | Current practices in studies applying the target trial emulation framework: a protocol for a systematic review | 2023 |
|
Andrew Bryant
| Human papillomavirus (HPV) self-sampling to encourage the uptake of cervical screening | 2023 |
|
Patience Kunonga
Dr Ryan Kenny
Margaret Astin
Andrew Bryant
Vasileios Kontogiannis
et al. | Predictive accuracy of risk prediction models for recurrence, metastasis and survival for early-stage cutaneous melanoma: a systematic review | 2023 |
|
Andrew Bryant
Dr Michael Grayling
Professor Dawn Craig
Professor Luke Vale
| Residual Disease after Primary Surgical Treatment for Advanced Epithelial Ovarian Cancer, Part 2: Network Meta-analysis Incorporating Expert Elicitation to Adjust for Publication Bias | 2023 |
|
Andrew Bryant
Eugenie Johnson
Dr Michael Grayling
Shaun Hiu
Dr Ahmed Elattar
et al. | Residual Disease Threshold After Primary Surgical Treatment for Advanced Epithelial Ovarian Cancer, Part 1: A Systematic Review and Network Meta-Analysis | 2023 |
|
Ellis Carter
Eugenie Johnson
Madeleine Still
Dr Aalya Al-Assaf
Andrew Bryant
et al. | Single‐incision sling operations for urinary incontinence in women | 2023 |
|
Andrew Bryant
| Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer | 2022 |
|
Andrew Bryant
Shaun Hiu
Patience Kunonga
Professor Dawn Craig
Professor Luke Vale
et al. | Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery | 2022 |
|
Shaun Hiu
Dr Theophile Bigirumurame
Patience Kunonga
Andrew Bryant
| Neuropsychiatric Inventory domains cluster into neuropsychiatric syndromes in Alzheimer;s disease: A systematic review and meta-analysis | 2022 |
|
